
Resorbable scaffold with everolimus-eluting stent shows superior efficacy over angioplasty in treating CLTI.


coremsg

A drug-eluting resorbable scaffold was superior to angioplasty in treating infrapopliteal artery disease and chronic limb-threating ischemia and was noninferior for safety in the LIFE-BTK trial.

Resorbable Scaffold Beats Angioplasty in Below-Knee CLTI

superior-efficacy-of-resorbable-scaffold-vs-angioplasty-in-below-knee-clti


Superior Efficacy of Resorbable Scaffold vs. Angioplasty in Below-Knee CLTI
